Sector Novavax, Inc.

Aandelen

NVAX

US6700024010

Biotechnologie & Medisch Onderzoek

Beurs gesloten - Nasdaq 22:00:00 21-04-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
8,490 USD -2,08% Intraday-grafiek van Novavax, Inc. +1,19% +26,34%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-2,08%+1,19%-11,75%-14,24%+26,34%+41,26%-2,19%-96,01%-92,28% 1,38 mld.
-2,85%-3,40%+9,49%-8,32%-4,98%-5,23%-11,01%-8,32%+220,38% 45,74 mld.
-1,81%+0,75%+13,45%-8,59%+2,80%+36,25%+20,84%+3,41%+951,19% 34,63 mld.
+1,83%+1,29%+55,46%+26,69%+86,94%+307,28%+513,01%+267,84% - 31,32 mld.
-0,61%+0,23%+5,79%-27,22%-22,06%+24,41%-13,16%-19,78%+150,88% 29,49 mld.
-1,22%+1,96%+0,50%-0,49%+12,15%+34,13%+31,79%-19,05%+168,94% 28,78 mld.
-2,07%-0,59%+10,19%+5,09%+12,69%+51,00%+201,23%+82,24%+1.271,52% 14,85 mld.
-2,56%-0,98%+13,79%-17,03%-8,32%+78,17%+172,42%+173,71% - 14,7 mld.
-0,26%+1,29%+13,56%-0,94%+11,15%+39,92%+13,44%-19,82%+119,04% 14,34 mld.
+1,07%-5,68%+3,76%+29,62%+35,24%+3.621,17%+3.898,31% - - 14,04 mld.
-0,12%-2,58%+5,34%-5,87%-5,47%+162,29%+102,49%+80,24%+70,81% 12,35 mld.
-2,87%+11,35%+17,44%-15,57%-6,60%+34,58% - - - 9,88 mld.
-0,51%-0,80%+14,26%+9,03%+15,64%+864,46%+2.023,61%-23,10% - 9,49 mld.
-1,50%+1,72%+15,91%-16,40%+1,46%+25,59%-28,51%-43,69%+154,13% 9,34 mld.
-2,58%-7,28%-10,42%-4,48%-18,60%+1.770,23%+569,40%+345,45%+824,53% 9,12 mld.
-1,32%+2,11%+19,21%-19,26%-8,21%+78,34%-8,86%-43,49%+126,55% 9,03 mld.
-1,66%+1,88%+15,53%-37,70%-36,79%-16,07%-44,39%-45,36%+56,28% 8,8 mld.
-2,29%-3,98%+0,43%-27,96%-15,29%-5,89%-20,32%-30,65%+43,85% 8,29 mld.
+0,14%-.--%-.--%-.--%-.--%+53,79%+163,93%+36,42%+605,12% 8,38 mld.
-1,67%-4,14%+14,55%-2,56%+5,80%+33,39%-11,49%-56,43% - 7,46 mld.
Gemiddelde -0,98%-0,38%+10,32%-6,81%+4,19%+361,45%+398,45%+32,42%+333,64% 16,07 mld.
Gewogen gemiddelde per kap. -1,01%-0,40%+13,24%-4,80%+7,55%+292,09%+331,64%+42,70%+382,46%
Biotechnologie & Medisch Onderzoek - Andere
  1. Beurs
  2. Aandelen
  3. Koers NVAX
  4. Sector Novavax, Inc.